Business Context and Reporting Period
This Form 8-K reports the consummation of the Initial Public Offering (IPO) by Alpha Healthcare Acquisition Corp. (the "Company"), a Special Purpose Acquisition Company (SPAC). The report date is September 22, 2020, covering events occurring on September 17, 2020. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
- IPO Gross Proceeds: $100,000,000 from the sale of 10,000,000 Units at $10.00 per Unit.
- Private Placement Proceeds: $3,550,000 from the sale of 355,000 Private Placement Units at $10.00 per Unit.
- Total Capital Raised: $103,550,000.
- Trust Account Funding: $100,000,000 deposited into a U.S.-based trust account. This amount includes $98,000,000 from IPO proceeds (incorporating $3,500,000 of deferred underwriting discount) and $2,000,000 from Private Placement proceeds.
- Warrant Exercise Price: $11.50 per share.
- Over-Allotment Option: Underwriters granted a 45-day option to purchase up to 1,500,000 additional Units.
Material Changes
The filing represents the Company's initial public listing and capital formation. There are no prior comparable periods for revenue or operating metrics as the Company was formed solely for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The primary material change is the transition from a private entity to a public company with $100 million in trust assets.
Outlook, Risks, and Contingencies
- Business Combination Deadline: The Company must complete an initial business combination within 24 months from the closing of the IPO (by September 22, 2022).
- Redemption Rights: Public shareholders may redeem their shares if the Company fails to complete a business combination within the 24-month period or in connection with specific amendments to the Certificate of Incorporation.
- Trust Account Restrictions: Funds in the trust account generally cannot be released until the completion of a business combination, a redemption event, or the liquidation of the Company. Interest earned may be used to pay taxes, with up to $100,000 reserved for dissolution expenses.
- Deferred Underwriting Discount: $3,500,000 of the underwriting discount is deferred and will be payable upon the completion of an initial business combination.
Investor Verification Checklist
- Verify the exact closing date of the IPO (September 22, 2020) versus the pricing date (September 17, 2020).
- Confirm the total amount held in the trust account ($100,000,000) and the composition of those funds.
- Review the terms of the over-allotment option (1,500,000 Units) and its expiration (45 days).
- Examine the Amended and Restated Certificate of Incorporation (Exhibit 3.1) for specific redemption thresholds and governance provisions.
- Check the status of the deferred underwriting discount ($3,500,000) and conditions for its payment.